SWEDISH ORPHAN BIOVITRUM AB |
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 253.2 SEK | -0.39% |
|
-2.98% | -4.79% |
| Mar. 14 | Certain Shares of Swedish Orphan Biovitrum AB are subject to a Lock-Up Agreement Ending on 14-MAR-2024. | CI |
| Feb. 13 | Sobi to Expand in South Korea via Rare Disease JV with Handok | MT |
Evolution of the average Target Price on Swedish Orphan Biovitrum AB
Price target over the last 5 years
History of analyst recommendation changes
5b48a9f14b8f9a639c.cY0PBJ4nyp3xhe-xCAhchM40xWJFngpy9ZwSTSJMOwc.QNhgbN91pO_E0rn-Xk8G6I1jqjUT9ycArPI_CkAgdkhF-1pI2G-t6KLTnA~afe2e7c73468af956140005350cfaff9
Analysts' Consensus
Sell
Buy
Mean consensus
BUY
Number of Analysts
9
Last Close Price
254.2
SEK
Average target price
314.1
SEK
Spread / Average Target
+23.57%
High Price Target
370
SEK
Spread / Highest target
+45.55%
Low Price Target
252
SEK
Spread / Lowest Target
-0.87%
Consensus detail
Consensus revision (last 18 months)
Trading Rating
Investor Rating
ESG Refinitiv
B+
EPS Revisions
- Stock Market
- Equities
- SOBI Stock
- Consensus Swedish Orphan Biovitrum AB
